Over the past year, Maggie’s Mission has raised $282,426 for MSK – 100% of this funding has supported vital pediatric cancer research, specifically a ground-breaking Malignant Rhabdoid Tumor research study. 

Malignant Rhabdoid Tumor (MRT) Research Study

Pediatric sarcomas are very rare bone or soft tissue cancers. There are more than 50 unique subtypes of sarcoma, including MRT, each of which may respond to a different targeted therapy. One way to personalize treatment is immunotherapy, which harnesses the power of the immune system to attack cancer cells. 

Maggie’s Mission is the sole funder of a game-changing MRT study at MSK. 

Thanks to donations to Maggie’s Mission, Dr. Alex Kentsis and Dr. Srikanth Ambati launched a new study that investigates the links between the genetics of MRT and treatment effectiveness. This data can then be used to match patients with specific mutations to the appropriate immunotherapy treatments and clinical trials, giving new hope to children battling this incredibly rare cancer. 

We all share a common goal: to cure children. Maggie’s Mission and its supporters are critical in making this happen. Click the links below to read about the research currently being done and research we hope to support in the future.

Our financials to date:

With your help, we have raised over $350,000 since September, 2017

What we are doing

Funded $282,426 towards the MRT Research project at Memorial Sloan Kettering


Provided $28,224 in financial assistance to local families affected by a pediatric cancer diagnosis


Donated $3,000 from our event "Music for Maggie" to two Harborfields High School students

Ronald McDonald House in NYC

Serving meals at the Ronald McDonald House in NYC - $3,837